Building the Next Generation of Pathbreaking Healthcare Companies.

Our unique process and organizational structure fuel our development of boundary-shifting healthcare technologies.

Turret Capital is a global biomedical investment and venture-building company. Headquartered in New York and with a presence in Asia, we maintain an international outlook to identify opportunities to help patients across the world.

Our Philosophy

We take a disciplined, process-oriented approach to investment and venture building. When we decide to build a new company, it is because it benefits from at least one of two distinct types of arbitrage opportunities between Asia and the US.

Arbitrage Opportunities

Innovation Arbitrage

Demand for the most sophisticated medical technologies in Asia is growing tremendously. However, many of the sources of advanced research and technology have neither the resources nor the institutional focus to expand into an extremely different and distant market. We work with these sources of innovation to launch new businesses focused on bringing these cutting-edge technologies to Asia and beyond.

Geographic Arbitrage

Asia is one of the largest and most exciting markets today. As its healthcare sector has accelerated in development, it has become a massive source of new patients and data. We will call on this acceleration in development and policy to validate new technologies far more quickly than would otherwise be possible. This expedited validation process will empower us to launch companies targeting untapped markets with unprecedented speed.

Our Process

As empiricists, we meticulously collect and analyze data and let that data inform our actions.

Identify Opportunities

First, we closely study areas of pressing concern to determine the highest levels of unmet medical need.

Aggregate Assets

Then, we select the most transformative technologies that show the greatest potential to raise the standard of care dramatically.

Build Team

After, we on-board the scientific and industry experts required to develop the technology and commercialize on a large scale.